Numerous clinical practice guidelines on the treatment of localized prostate cancer exist, but methodological quality varies considerably. A new report evaluates published guidelines, assessing the rigour and applicability of the recommendations and suggesting areas that require improvement.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Gupta, M. et al. Clinical practice guidelines on prostate cancer: a critical appraisal. J. Urol. http://dx.doi.org/10.1016/j.juro.2014.10.105.
Dahm, P., Yeung, L. L., Chang, S. S. & Cookson, M. S. A critical review of clinical practice guidelines for the management of clinically localized prostate cancer. J. Urol. 180, 451–460 (2008).
Brouwers, M. C. et al. AGREE II: Advancing guideline development, reporting and evaluation in health care. J. Clin. Epidemiol. 63, 1308–1311 (2010).
National Institute of Health and Care Excellence. Prostate cancer: diagnosis and treatment. Clinical guideline CG175. National Institute of Health and Care Excellence [online], (2014).
American Urological Association. Guideline for the management of clinically localized prostate cancer. American Urological Association [online], (2007).
Capacity Enhancement Program of the Cancer Guidelines Advisory Group, Canadian Partnership Against Cancer. Cancer practice guidelines status report: prostate cancer. Cancerview.ca [online], (2010).
Watine, J. et al. Conflict between guideline methodologic quality and recommendation validity: a potential problem for practitioners. Clin. Chem. 52, 65–72 (2006).
Brouwers, M. C. et al. The Global Rating Scale complements the AGREE II in advancing the quality of practice guidelines. J. Clin. Epidemiol. 65, 526–534 (2012).
Jakes, A. D., Marec-Berard, P., Phillips, R. S. & Stark, D. P. Critical review of clinical practice guidelines for fertility preservation in teenagers and young adults with cancer. J. Adolesc. Young Adult Oncol. 3, 144–152 (2014).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.G. declares that he is Director of the National Collaborating Centre for Cancer, which is funded by NICE to produce cancer guidelines, is principal investigator of a trial of 223Ra in prostate cancer funded by Bayer Pharmaceuticals and is an investigator on a number of clinical trials supported by National Cancer Research Institute.
Rights and permissions
About this article
Cite this article
Graham, J. How good are guidelines for localized prostate cancer?. Nat Rev Urol 12, 127–128 (2015). https://doi.org/10.1038/nrurol.2015.3
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2015.3
